Nuveen’s BioNTech BNTX Stock Holding History

Nuveen’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,300	Closed	-$4K	–	3264
2022 Q1	$4K	Buy	+24,300	New	+$4.08M	﹤0.01%	3334
2021 Q4	–	Sell	-24,300	Closed	-$7K	–	3330
2021 Q3	$7K	Hold	24,300	–	–	﹤0.01%	3339
2021 Q2	$5K	Buy	+24,300	New	+$4.58M	﹤0.01%	3308

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's BNTX Position: Q2 2023 in Review

Nuveen sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 162,518 shares — an estimated $20.2M sold.

Nuveen first reported a position in BNTX in Q1 2021 and held it in 9 quarters. The position peaked at $51.3M in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

Nuveen reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
Nuveen sold 162,518 BioNTech shares in Q2 2023, an estimated $20.2M.
Nuveen first reported a position in BioNTech in Q1 2021 and held it in 9 quarters.
Nuveen's BioNTech position peaked at $51.3M in Q3 2021.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.